Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8963 |
High Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.8815 |
High Similarity |
NPD4908 |
Phase 1 |
0.8571 |
High Similarity |
NPD1610 |
Phase 2 |
0.8369 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.8369 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.8271 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.8214 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.8201 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.8169 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.8169 |
Intermediate Similarity |
NPD1613 |
Approved |
0.8156 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.8043 |
Intermediate Similarity |
NPD4749 |
Approved |
0.8029 |
Intermediate Similarity |
NPD1091 |
Approved |
0.7962 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7933 |
Intermediate Similarity |
NPD5058 |
Phase 3 |
0.7887 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7853 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7852 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.7832 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7817 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7763 |
Intermediate Similarity |
NPD7212 |
Phase 2 |
0.7763 |
Intermediate Similarity |
NPD7213 |
Phase 3 |
0.7733 |
Intermediate Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.7722 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7712 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7712 |
Intermediate Similarity |
NPD7447 |
Phase 1 |
0.7711 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7707 |
Intermediate Similarity |
NPD37 |
Approved |
0.7692 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7683 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7682 |
Intermediate Similarity |
NPD7466 |
Approved |
0.7677 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7673 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7673 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7673 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7658 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7655 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7643 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7643 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7584 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7584 |
Intermediate Similarity |
NPD5588 |
Approved |
0.7578 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7576 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7566 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7551 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7547 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.753 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7517 |
Intermediate Similarity |
NPD4537 |
Clinical (unspecified phase) |
0.7517 |
Intermediate Similarity |
NPD7097 |
Phase 1 |
0.7517 |
Intermediate Similarity |
NPD4538 |
Approved |
0.7517 |
Intermediate Similarity |
NPD4536 |
Approved |
0.75 |
Intermediate Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7485 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7485 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7485 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7484 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7484 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7483 |
Intermediate Similarity |
NPD6006 |
Clinical (unspecified phase) |
0.7483 |
Intermediate Similarity |
NPD6005 |
Phase 3 |
0.7483 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7483 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7483 |
Intermediate Similarity |
NPD6003 |
Clinical (unspecified phase) |
0.7483 |
Intermediate Similarity |
NPD6002 |
Phase 3 |
0.7483 |
Intermediate Similarity |
NPD6004 |
Phase 3 |
0.7483 |
Intermediate Similarity |
NPD8651 |
Approved |
0.7453 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7451 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.744 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7434 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7421 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7417 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7417 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7413 |
Intermediate Similarity |
NPD3600 |
Clinical (unspecified phase) |
0.7407 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7396 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7391 |
Intermediate Similarity |
NPD6671 |
Approved |
0.7376 |
Intermediate Similarity |
NPD5125 |
Phase 3 |
0.7376 |
Intermediate Similarity |
NPD5126 |
Approved |
0.7361 |
Intermediate Similarity |
NPD6696 |
Suspended |
0.7353 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7351 |
Intermediate Similarity |
NPD4108 |
Discontinued |
0.7351 |
Intermediate Similarity |
NPD5960 |
Phase 3 |
0.7338 |
Intermediate Similarity |
NPD3892 |
Phase 2 |
0.7333 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7329 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7329 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7321 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.732 |
Intermediate Similarity |
NPD2424 |
Discontinued |
0.7317 |
Intermediate Similarity |
NPD5494 |
Approved |
0.731 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7303 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7294 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7289 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7285 |
Intermediate Similarity |
NPD4978 |
Clinical (unspecified phase) |
0.7273 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7267 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7267 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7267 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7255 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7251 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7246 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7244 |
Intermediate Similarity |
NPD6667 |
Approved |
0.7244 |
Intermediate Similarity |
NPD6666 |
Approved |
0.7239 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7237 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7237 |
Intermediate Similarity |
NPD3748 |
Approved |
0.72 |
Intermediate Similarity |
NPD4140 |
Approved |
0.72 |
Intermediate Similarity |
NPD2238 |
Phase 2 |
0.7195 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7181 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7172 |
Intermediate Similarity |
NPD3685 |
Discontinued |
0.7171 |
Intermediate Similarity |
NPD7119 |
Phase 2 |
0.7161 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7153 |
Intermediate Similarity |
NPD3705 |
Approved |
0.7152 |
Intermediate Similarity |
NPD5735 |
Approved |
0.7151 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD5762 |
Approved |
0.7143 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7143 |
Intermediate Similarity |
NPD7157 |
Approved |
0.7143 |
Intermediate Similarity |
NPD5763 |
Approved |
0.7132 |
Intermediate Similarity |
NPD2684 |
Approved |
0.7126 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7123 |
Intermediate Similarity |
NPD3225 |
Approved |
0.7113 |
Intermediate Similarity |
NPD7741 |
Discontinued |
0.7111 |
Intermediate Similarity |
NPD968 |
Approved |
0.7091 |
Intermediate Similarity |
NPD7975 |
Clinical (unspecified phase) |
0.7089 |
Intermediate Similarity |
NPD7040 |
Clinical (unspecified phase) |
0.7089 |
Intermediate Similarity |
NPD7041 |
Phase 2 |
0.7081 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7081 |
Intermediate Similarity |
NPD8158 |
Clinical (unspecified phase) |
0.7068 |
Intermediate Similarity |
NPD846 |
Approved |
0.7068 |
Intermediate Similarity |
NPD940 |
Approved |
0.7067 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7063 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7059 |
Intermediate Similarity |
NPD290 |
Approved |
0.7055 |
Intermediate Similarity |
NPD6582 |
Phase 2 |
0.7055 |
Intermediate Similarity |
NPD5327 |
Phase 3 |
0.7055 |
Intermediate Similarity |
NPD6583 |
Phase 3 |
0.7052 |
Intermediate Similarity |
NPD7549 |
Discontinued |
0.7051 |
Intermediate Similarity |
NPD2800 |
Approved |
0.705 |
Intermediate Similarity |
NPD1138 |
Approved |
0.705 |
Intermediate Similarity |
NPD7843 |
Approved |
0.705 |
Intermediate Similarity |
NPD5535 |
Approved |
0.7044 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7044 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7044 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7027 |
Intermediate Similarity |
NPD3691 |
Phase 2 |
0.7027 |
Intermediate Similarity |
NPD3690 |
Phase 2 |
0.7027 |
Intermediate Similarity |
NPD6584 |
Phase 3 |
0.7021 |
Intermediate Similarity |
NPD6387 |
Discontinued |
0.7012 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7011 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7011 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7006 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7006 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7006 |
Intermediate Similarity |
NPD4535 |
Phase 3 |
0.6994 |
Remote Similarity |
NPD6072 |
Discontinued |
0.6993 |
Remote Similarity |
NPD4097 |
Suspended |
0.6993 |
Remote Similarity |
NPD6353 |
Approved |
0.6987 |
Remote Similarity |
NPD970 |
Clinical (unspecified phase) |
0.6987 |
Remote Similarity |
NPD7037 |
Approved |
0.6981 |
Remote Similarity |
NPD1511 |
Approved |
0.698 |
Remote Similarity |
NPD3018 |
Phase 2 |
0.6978 |
Remote Similarity |
NPD1139 |
Approved |
0.6978 |
Remote Similarity |
NPD1137 |
Approved |
0.6974 |
Remote Similarity |
NPD1240 |
Approved |
0.6972 |
Remote Similarity |
NPD7340 |
Approved |
0.697 |
Remote Similarity |
NPD5402 |
Approved |
0.6968 |
Remote Similarity |
NPD1551 |
Phase 2 |
0.6968 |
Remote Similarity |
NPD2935 |
Discontinued |
0.6959 |
Remote Similarity |
NPD3751 |
Discontinued |
0.6957 |
Remote Similarity |
NPD4750 |
Phase 3 |
0.6957 |
Remote Similarity |
NPD920 |
Approved |
0.6948 |
Remote Similarity |
NPD2200 |
Suspended |
0.6944 |
Remote Similarity |
NPD4360 |
Phase 2 |
0.6944 |
Remote Similarity |
NPD1357 |
Approved |
0.6944 |
Remote Similarity |
NPD4363 |
Phase 3 |
0.6937 |
Remote Similarity |
NPD5401 |
Approved |
0.6932 |
Remote Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.6928 |
Remote Similarity |
NPD3882 |
Suspended |
0.6927 |
Remote Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.6923 |
Remote Similarity |
NPD7030 |
Discontinued |
0.6917 |
Remote Similarity |
NPD3020 |
Approved |
0.6909 |
Remote Similarity |
NPD5929 |
Approved |
0.6908 |
Remote Similarity |
NPD6233 |
Phase 2 |
0.6903 |
Remote Similarity |
NPD3846 |
Clinical (unspecified phase) |
0.6903 |
Remote Similarity |
NPD2799 |
Discontinued |
0.6899 |
Remote Similarity |
NPD6331 |
Phase 2 |
0.6898 |
Remote Similarity |
NPD7584 |
Approved |
0.6897 |
Remote Similarity |
NPD7685 |
Pre-registration |
0.6897 |
Remote Similarity |
NPD6516 |
Phase 2 |
0.6897 |
Remote Similarity |
NPD5846 |
Approved |
0.6897 |
Remote Similarity |
NPD4626 |
Approved |
0.6894 |
Remote Similarity |
NPD1512 |
Approved |
0.6887 |
Remote Similarity |
NPD7095 |
Approved |
0.6885 |
Remote Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.6883
|
Remote Similarity |
NPD2157 |
Approved |